New balloon treatment shows promise for leg artery disease

NCT ID NCT05556681

Completed Disease control Sponsor: C. R. Bard Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special balloon coated with sirolimus, a drug that helps keep arteries open, in 34 people with peripheral artery disease (narrowed leg arteries). The goal was to see if the balloon is safe and works well at improving blood flow and symptoms like leg pain. Participants had one or two blockages in their leg arteries and were followed for six months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

peripheral arterial disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL ARTERIAL DISEASE PERIPHERAL ARTERY DISEASE STENOSIS ARTERY

Contacts and locations

Locations

Auckland City Hospital

Grafton, Auckland, 1023, New Zealand
Flinders University

Adelaide, South Australia, 5001, Australia
Gold Coast University Hospital

Southport, Queensland, 4215, Australia
Royal North Shore Hospital

St Leonards, New South Wales, 2065, Australia
Royal Perth Hospital

Perth, Western Australia, 6000, Australia
Royal Prince Alfred Hospital

Camperdown, New South Wales, 2050, Australia
Sengkang General Hospital

Punggol, 544886, Singapore
Tan Tock Seng Hospital

Novena, 308433, Singapore
The Alfred

Melbourne, Victoria, 3004, Australia
Waikato Hospital

Hamilton, Waikato Region, 3204, New Zealand

More trials for these conditions

Other studies related to the condition(s) this trial covers.